Having trouble viewing this email? View in your browser.
img Mirai Genomics

Globally, more than 200 million confirmed cases of COVID-19, including more than 4 million deaths globally, have been reported to the World Health Organization for now. The COVID-19 outbreak has assigned the health service representatives worldwide a serious task of rapid diagnostics and timely medical care provision.

In Mirai Genomics, we believe the highly sensitive POC molecular diagnostic tests are a helping hand and respond to the public health threat with LifePad – fast, portable, cost-effective, and easy- to-use molecular diagnostic test.

Ensuring the LoD on the level of 1,000 copies per mL, we provide the users of our POC instruments with a RT-PRC sensitivity and accuracy, delivering the amplification results in 40 minutes. LifePads could be combined into clusters (up to 96 devices) and become a new-generation POCT LAB. It is up to you how to combine your ideal lab and even in a post-pandemic period you could divide your cluster into smaller systems.


Would you like to find out more?
Visit our website to learn more about us or simply drop us a line at miraigenomics@miraigenomics.com

You have received this email as a contact of ESCMID or one of its affiliated societies.
You can unsubscribe or change your newsletter subscriptions here.